Invention Grant
- Patent Title: Therapeutic apoptotic cells for cancer therapy
-
Application No.: US16576734Application Date: 2019-09-19
-
Publication No.: US11951126B2Publication Date: 2024-04-09
- Inventor: Shai Novik , Dror Mevorach
- Applicant: Enlivex Therapeutics RDO Ltd
- Applicant Address: IL Nes-Ziona
- Assignee: Enlivex Therapeutics RDO Ltd
- Current Assignee: Enlivex Therapeutics RDO Ltd
- Current Assignee Address: IL Nes-Ziona
- Agency: PEARL COHEN ZEDEK LATZER BARATZ LLP
- Agent Mark S. Cohen
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K9/00 ; A61K38/17 ; A61K39/395 ; A61P35/00 ; A61P35/02 ; C12N5/078

Abstract:
Methods of use of early apoptotic cell populations and compositions thereof disclosed herein, including methods of treating a cancer or a tumor, extending survival times of a subject suffering from a cancer or a tumor, and reducing the size or reducing the growth rate of a cancer or a tumor, wherein subjects are administered apoptotic cells or compositions thereof. Cancers may include solid tumors or diffuse cancers, for example leukemia. In certain instances compositions may include additional chemotherapeutic agent. Further, inactivated early apoptotic cell populations are disclosed and methods of making the same.
Public/Granted literature
- US20200009192A1 THERAPEUTIC APOPTOTIC CELLS FOR CANCER THERAPY Public/Granted day:2020-01-09
Information query
IPC分类: